BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33800107)

  • 1. Loss of FADD and Caspases Affects the Response of T-Cell Leukemia Jurkat Cells to Anti-Cancer Drugs.
    Mrkvová Z; Portešová M; Slaninová I
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor α-induced necroptosis.
    Laukens B; Jennewein C; Schenk B; Vanlangenakker N; Schier A; Cristofanon S; Zobel K; Deshayes K; Vucic D; Jeremias I; Bertrand MJ; Vandenabeele P; Fulda S
    Neoplasia; 2011 Oct; 13(10):971-9. PubMed ID: 22028622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.
    Hannes S; Abhari BA; Fulda S
    Cancer Lett; 2016 Sep; 380(1):31-8. PubMed ID: 27267809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis.
    Yang C; Ran Q; Zhou Y; Liu S; Zhao C; Yu X; Zhu F; Ji Y; Du Q; Yang T; Zhang W; He S
    Apoptosis; 2020 Jun; 25(5-6):441-455. PubMed ID: 32418059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis.
    Chromik J; Safferthal C; Serve H; Fulda S
    Cancer Lett; 2014 Mar; 344(1):101-109. PubMed ID: 24184825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP; Chow SC
    FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulated Ectonucleotidases in Fas-Associated Death Domain Protein- and Receptor-Interacting Protein Kinase 1-Deficient Jurkat Leukemia Cells Counteract Extracellular ATP/AMP Accumulation via Pannexin-1 Channels during Chemotherapeutic Drug-Induced Apoptosis.
    Boyd-Tressler AM; Lane GS; Dubyak GR
    Mol Pharmacol; 2017 Jul; 92(1):30-47. PubMed ID: 28461585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8.
    Ikner A; Ashkenazi A
    J Biol Chem; 2011 Jun; 286(24):21546-54. PubMed ID: 21525013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines.
    Cekay MJ; Roesler S; Frank T; Knuth AK; Eckhardt I; Fulda S
    Cancer Lett; 2017 Dec; 410():228-237. PubMed ID: 28923396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Necroptosis in Human Breast Cancer Drug-Resistant Cells by SMAC Analog LCL161 After Caspase Inhibition Requires RIP3.
    Jin G; Liu Y; Xu P; Jin G
    Pharmazie; 2019 Jun; 74(6):363-368. PubMed ID: 31138375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1.
    Zheng L; Bidere N; Staudt D; Cubre A; Orenstein J; Chan FK; Lenardo M
    Mol Cell Biol; 2006 May; 26(9):3505-13. PubMed ID: 16611992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells.
    Czaplinski S; Abhari BA; Torkov A; Seggewiß D; Hugle M; Fulda S
    Oncotarget; 2015 Dec; 6(39):41522-34. PubMed ID: 26575016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.
    Feldmann F; Schenk B; Martens S; Vandenabeele P; Fulda S
    Oncotarget; 2017 Sep; 8(40):68208-68220. PubMed ID: 28978109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycemic Conditions Prime Cells for RIP1-dependent Necroptosis.
    LaRocca TJ; Sosunov SA; Shakerley NL; Ten VS; Ratner AJ
    J Biol Chem; 2016 Jun; 291(26):13753-61. PubMed ID: 27129772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smac mimetic sensitizes renal cell carcinoma cells to interferon-α-induced apoptosis.
    Reiter M; Eckhardt I; Haferkamp A; Fulda S
    Cancer Lett; 2016 May; 375(1):1-8. PubMed ID: 26912071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spy1 induces de-ubiquitinating of RIP1 arrest and confers glioblastoma's resistance to tumor necrosis factor (TNF-α)-induced apoptosis through suppressing the association of CLIPR-59 and CYLD.
    Ding Z; Liu Y; Yao L; Wang D; Zhang J; Cui G; Yang X; Huang X; Liu F; Shen A
    Cell Cycle; 2015; 14(13):2149-59. PubMed ID: 26017671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the ripoptosome and its components: implications for anti-inflammatory and cancer therapy.
    Schilling R; Geserick P; Leverkus M
    Methods Enzymol; 2014; 545():83-102. PubMed ID: 25065887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel smac mimetic ASTX660 (Tolinapant) and TNF-α synergistically induce necroptosis in bladder cancer cells in vitro upon apoptosis inhibition.
    Wang L; Hu C; Zhao Y; Hu X
    Biochem Biophys Res Commun; 2022 Apr; 602():8-14. PubMed ID: 35247703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species regulate Smac mimetic/TNFα-induced necroptotic signaling and cell death.
    Schenk B; Fulda S
    Oncogene; 2015 Nov; 34(47):5796-806. PubMed ID: 25867066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis.
    Steinhart L; Belz K; Fulda S
    Cell Death Dis; 2013 Sep; 4(9):e802. PubMed ID: 24030154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.